1-6 of 6
Jasmina Georgievski
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Integrative genomic analysis reveals cancer-associated mutations at diagnosis of CML in patients with high-risk disease

Clinical Trials & Observations
Susan Branford, Paul Wang, David T. Yeung, Daniel Thomson, Adrian Purins, Carol Wadham, Nur Hezrin Shahrin, Justine E. Marum, Nathalie Nataren, Wendy T. Parker, Joel Geoghegan, Jinghua Feng, Naranie Shanmuganathan, Martin C. Mueller, Christian Dietz, Doris Stangl, Zoe Donaldson, Haley Altamura, Jasmina Georgievski, Jodi Braley, Anna Brown, Christopher Hahn, Ieuan Walker, Soo-Hyun Kim, Soo-Young Choi, Sa-Hee Park, Dong-Wook Kim, Deborah L. White, Agnes S. M. Yong, David M. Ross, Hamish S. Scott, Andreas W. Schreiber, Timothy P. Hughes
Journal: Blood
Blood (2018) 132 (9): 948–961.
https://doi.org/10.1182/blood-2018-02-832253
Published: 2018
Includes: Supplemental data
Journal Articles

Paper or plastic? BCR-ABL1 quantitation and mutation detection from dried blood spots

Olga Sala Torra, Lan Beppu, Jordan L. Smith, Linda Welden, Jasmina Georgievski, Karisma Gupta, Rashmi Kumar, Cecilia C. S. Yeung, Amy Paguirigan, Ted A. Gooley, Susan Branford, Jerald P. Radich
Journal: Blood
Blood (2016) 127 (22): 2773–2774.
https://doi.org/10.1182/blood-2015-12-689059
Published: 2016
Includes: Supplemental data
Journal Articles

BCR-ABL Assay Sensitivity of MR4.5 Achieved in >90%, and MR5 in >75% of Samples, through mRNA Selection before qRT-PCR

David T Yeung, BSc, MBBS, FRACP, FRCPA, Wendy Tara Parker, PhD, Stuart Phillis, B Biotech, Jasmina Georgievski, BSc, Hamish S Scott, BSc, PhD FFSc (RCPA), Timothy P. Hughes, MD MBBS, FRACP, FRCPA, Susan Branford, PhDFFSc (RCPA)
Journal: Blood
Blood (2015) 126 (23): 2777.
https://doi.org/10.1182/blood.V126.23.2777.2777
Published: 2015
Journal Articles

Prognosis for patients with CML and >10% BCR-ABL1 after 3 months of imatinib depends on the rate of BCR-ABL1 decline

Clinical Trials & Observations
Susan Branford, David T. Yeung, Wendy T. Parker, Nicola D. Roberts, Leanne Purins, Jodi A. Braley, Haley K. Altamura, Alexandra L. Yeoman, Jasmina Georgievski, Bronte A. Jamison, Stuart Phillis, Zoe Donaldson, Mary Leong, Linda Fletcher, John F. Seymour, Andrew P. Grigg, David M. Ross, Timothy P. Hughes
Journal: Blood
Blood (2014) 124 (4): 511–518.
https://doi.org/10.1182/blood-2014-03-566323
Published: 2014
Includes: Supplemental data
Journal Articles

Early molecular response and female sex strongly predict stable undetectable BCR-ABL1 , the criteria for imatinib discontinuation in patients with CML

Clinical Trials & Observations
Susan Branford, David T. Yeung, David M. Ross, Jodi A. Prime, Chani R. Field, Haley K. Altamura, Alexandra L. Yeoman, Jasmina Georgievski, Bronte A. Jamison, Stuart Phillis, Brad Sullivan, Nancy E. Briggs, Mark Hertzberg, John F. Seymour, John Reynolds, Timothy P. Hughes
Journal: Blood
Blood (2013) 121 (19): 3818–3824.
https://doi.org/10.1182/blood-2012-10-462291
Published: 2013
Journal Articles

Early Molecular Response and Female Sex Strongly Predict Achievement of Stable Undetectable BCR-ABL1 , a Criterion for Imatinib Discontinuation in Patients with CML

Susan Branford, PhD, David Ross, MBBS, PhD, Jodi Prime, BSc., Chani Field, BSc, Haley Altamura, BSc, Alexandra Yeoman, BSc, Jasmina Georgievski, BSc, Stuart Phillis, BSc, Bronte A Jamison, BSc, Brad Sullivan, BSc, David T Yeung, BSc, MBBS, FRACP, FRCPA, Timothy Hughes, MD, MBBS
Journal: Blood
Blood (2012) 120 (21): 165.
https://doi.org/10.1182/blood.V120.21.165.165
Published: 2012